Perspective Therapeutics, Inc.

CATX

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001748615-26-000002
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026
Reporting Owners: Morich Frank (Director)

Summary

Type

Neutral

Net shares

0

% of shares

0.00%

Amount (USD)

$0

Insider confidence score

52.5 out of 100

Positive

  • Minimal sell amount (<$10K)

Derivative Transactions

Transaction 1

Security

Stock option (right to buy)

Action

Grant

Date

2026-03-02

Code

A

Net shares

+50,000.0

Acquired/Disposed

Acquired

Shares Owned Before

0.0

Shares Owned After

50,000.0

Filing's footnotes

1. The option grant was approved by the Issuer's Board of Directors on January 26, 2026, with a grant date of March 2, 2026, and represents the Reporting Person's annual equity award for 2026.

2. Option vests in full on March 2, 2027, subject to the Reporting Person's continued service on the vesting date.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.